Browsing by Subject Cancer -- Treatment

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 32 to 48 of 48 < previous 
Issue DateTitleAuthor(s)
2014New modalities for cancer therapyCauchi, Maurice N.
2020Oncology without tissue diagnosis?Cilia-Vincenti, Albert
2021An overview of the role of long non-coding RNAs in human choriocarcinomaDi Fiore, Riccardo; Suleiman, Sherif; Felix, Ana; O’Toole, Sharon A.; O’Leary, John J.; Ward, Mark P.; Beirne, James P.; Sabol, Maja; Ozretić, Petar; Yordanov, Angel; Vasileva-Slaveva, Mariela; Kostov, Stoyan; Nikolova, Margarita; Said-Huntingford, Ian; Ayers, Duncan; Ellul, Bridget; Pentimalli, Francesca; Giordano, Antonio; Calleja-Agius, Jean
2016Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosisCarlisi, D.; Buttitta, G.; Di Fiore, Riccardo; Scerri, Christian A.; Drago-Ferrante, R.; Vento, R.; Tesoriere, G.
2017Parthenolide prevents resistance of MDA-MB231 cells to doxorubicin and mitoxantrone : the role of Nrf2Carlisi, Daniela; De Blasio, Anna; Drago-Ferrante, Rosa; Di Fiore, Riccardo; Buttitta, Giuseppina; Monreale, Marco; Scerri, Christian A.; Vento, Renza; Tesoriere, Giovanni
2011Patient knowledge of colorectal cancer therapy side effectsPirotta, Ilona; Serracino-Inglott, Anthony; Azzopardi, Lilian M.; Anastasi, Alison
1993Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonographyJacobs, Ian; Davies, Ann Prys; Bridges, Jane; Stabile, Isabel; Fay, Toby; Lower, Adrian; Grudzinskas, J. G.; Oram, David
2022Prognostic signifience of molecular genetic factors in endometrial cancer. A modern approach to the problemTripac, Irina; Stratan, Valentina; Tutuianu, Valeriu; Sitnic, Victor; Faraggi, David; Calleja-Agius, Jean
2005Quality of life after treatment for breast cancerCardona Venes, Sylvana
2021Rational design and preliminary validation of novel 6-phosphogluconate dehydrogenase (6PGD) inhibitors using parietin as a leadSinagra, Daniel (2021)
2021Rational design and preliminary validation of novel glutaminase C modulatorsZammit, Lara (2021)
2020The rational design of acid ceramidase inhibitorsAbela, Gabriel
2019Testicular germ-cell tumours and penile squamous cell carcinoma : appropriate management makes the differenceNicolai, Nicola; Biasoni, Davide; Catanzaro, Mario A.; Colecchia, Maurizio; Trama, Annalisa; Calleja, Neville
2021Therapeutic potential of ecdysteroids and steroidal alkaloids on solid cancersCutajar, Catriona; Farrugia, Mariah; Calleja-Agius, Jean; Schembri-Wismayer, Pierre
2013Totarol content and cytotoxicity varies significantly in different types of propolisZammit, Elizabeth Jane; Theuma, Krystle Blair; Darmanin, Stephanie; Muraglia, Marilena; Camilleri-Podesta, Marie Therese; Buhagiar, Joseph A.; Calleja-Agius, Jean; Zarb Adami, Maurice; Franchini, Carlo; Schembri-Wismayer, Pierre; Micallef, Mark
2020Tumor formalin fixed vaccines and secondary immune response to elicit a therapeutic immune response in solid tumorsTadic, Srdjan (2020)
2020Volatilomic analyses of Tuscan Juniperus oxycedrus L. and in vitro cytotoxic effect of its essential oils on human cell linesNajar, Basma; Pistelli, Luisa; Buhagiar, Joseph A.